The Alberta Medical Association says the provincial government needs to recruit more cancer oncologists to prevent more Albertans from dying while waiting for treatment.
Researchers in the United Kingdom (UK) have found that new blood test can predict if breast cancer will return years before the disease shows up on scans. Results of the study were presented at the American Society of Clinical Oncology …
"Cutting back on meds. Cutting back on doctor visits. Losing your home. Cutting back on food—these are not things that we want to believe happen to people with cancer in this country." That's the deep type of financial stress that…
International cancer experts presented their findings for ovarian, esophageal cancer and Hodgkin lymphoma at the American Society of Clinical Oncology annual meeting.
(MedPage Today) -- CHICAGO -- The investigational CD40 agonist mitazalimab and modified FOLFIRINOX demonstrated encouraging activity in patients with previously untreated metastatic pancreatic ductal adenocarcinoma, according to the phase…
GSK’s multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage study presented at a medical meeting on…
A new set of targeted and immune-boosting drugs can add months or even years to life expectancy according to results released this weekend at a top conference.
AstraZeneca and Daiichi Sankyo’s Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug,…